Ramin Farzaneh-Far

Ramin Farzaneh-Far is a declared insider of Ra Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 35 filings, for trades running from 1 February 2019 to 2 April 2020.

The open-market record consists of 12 sales worth €3.7M, with no purchase. Outside the open market, there are 1 share grant and 21 option exercises. Since January 2020: no purchases and 3 sales on the market.

The latest filing, published on 3 April 2020, reports a transaction of €641k in Ra Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.